Overexpression of protein kinase C-beta1 isoenzyme suppresses SC-236-induced apoptosis in gastric cancer cells

2001 ◽  
Vol 120 (5) ◽  
pp. A664-A665 ◽  
Author(s):  
X JIANG ◽  
S LAM ◽  
H KUNG ◽  
M LIN ◽  
A KOKI ◽  
...  
2001 ◽  
Vol 120 (5) ◽  
pp. A664-A665 ◽  
Author(s):  
Xiaohua Jiang ◽  
S.K. Lam ◽  
H.F. Kung ◽  
Marie C.M. Lin ◽  
Alane T. Koki ◽  
...  

1995 ◽  
Vol 87 (18) ◽  
pp. 1394-1399 ◽  
Author(s):  
G. K. Schwartz ◽  
A. Haimovitz-Friedman ◽  
S. K. Dhupar ◽  
D. Ehleiter ◽  
P. Maslak ◽  
...  

2017 ◽  
Vol 37 (2) ◽  
Author(s):  
Na Li ◽  
Wei Zhang

Recently, autophagy has been indicated to play an essential role in various biological events, such as the response of cervical cancer cells to chemotherapy. However, the exact signalling mechanism that regulates autophagy during chemotherapy remains unclear. In the present study, we investigated the regulation by cisplatin on protein kinase C β (PKC β), on B-cell lymphoma 2 (Bcl-2) and on apoptosis in cervical cancer Hela cells. And then we examined the regulation by cisplatin on autophagy and the role of autophagy on the chemotherapy in Hela cells. In addition, the regulation of the PKC β on the autophagy was also investigated. Our results indicated that cisplatin promoted PKC β in Hela cells. The PKC β inhibitor reduced the cisplatin-induced apoptosis, whereas increased the cisplatin-induced autophagy in Hela cells. On the other side, the PKC β overexpression aggravated the cisplatin-induced apoptosis, whereas down-regulated the cisplatin-induced autophagy. Taken together, our study firstly recognized the involvement of PKC β in the cytotoxicity of cisplatin via inhibiting autophagy in cervical cancer cells. We propose that PKC β would sensitize cervical cancer cells to chemotherapy via reducing the chemotherapy induced autophagy in cancer cells.


2019 ◽  
Vol 67 (5) ◽  
pp. 856-861 ◽  
Author(s):  
Yongning Jia ◽  
Ziyu Li ◽  
Xiaojing Cheng ◽  
Xiaojiang Wu ◽  
Fei Pang ◽  
...  

Previously, we demonstrated that death-associated protein-3 (DAP3) loss drives chemoresistance in gastric cancer cells. In the present study, we aimed to determine the underlying molecular mechanism. The effect of DAP3 silencing on β-catenin signaling was assessed. The direct mediator of DAP3 silencing-induced chemoresistance was identified. Depletion of DAP3 stimulates nuclear accumulation of β-catenin and enhances β-catenin-dependent transcriptional activity in gastric cancer cells. However, the protein kinase B , , extracellular regulated protein kinase and signal transducer and activator of transcription 3 signaling pathways remain unaffected by DAP3 loss. We found that the downstream target gene LGR5 (leucine-rich G-protein coupled receptor 5) is upregulated in DAP3-depleted gastric cancer cells. Moreover, knockdown of LGR5 resensitizes DAP3-depleted gastric cancer cells to 5-fluorouracil (5-FU) and oxaliplatin. We also observed that ectopic expression of LGR5 reduces apoptosis in gastric cancer cells on treatment with 5-FU and oxaliplatin, which is accompanied by prevention of caspase-3 cleavage. The antiapoptotic protein Bcl-2 is identified as a key mediator of LGR5-induced apoptosis resistance in gastric cancer cells. The present findings indicate that DAP3 deficiency-induced chemoresistance in gastric cancer is at least partially mediated through the β-catenin/LGR5/Bcl-2 axis. Targeting LGR5 may provide a novel strategy to overcome chemoresistance in DAP3-deficient gastric cancer cells.


2000 ◽  
Vol 275 (11) ◽  
pp. 7574-7582 ◽  
Author(s):  
Teruhiko Fujii ◽  
Marı́a Laura Garcı́a-Bermejo ◽  
Juan Lucas Bernabó ◽  
Jorge Caamaño ◽  
Motoi Ohba ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document